Deciphering the role of mitochondria in human fungal drug resistance. [PDF]
MycologyMa Y +5 more
europepmc +1 more source
The target site of the novel fungicide quinofumelin, Pyricularia oryzae class II dihydroorotate dehydrogenase. [PDF]
J Pestic Sci, 2022 Higashimura N +5 more
europepmc +1 more source
Trends of Azole-Resistant Aspergillus Fumigatus Susceptibility Over 12 Years from a German ECMM Excellence Center. [PDF]
MycopathologiaVerhasselt HL +6 more
europepmc +1 more source
Drug Discovery and Repurposing for <i>Coccidioides</i>: A Systematic Review. [PDF]
J Fungi (Basel)Saeger S +5 more
europepmc +1 more source
Boronic acid derivatives inhibit Candida albicans growth by compromising energy metabolism. [PDF]
J Adv ResWu S +12 more
europepmc +1 more source
Recent innovations and challenges in the treatment of fungal infections. [PDF]
Front Cell Infect MicrobiolLiu D, Zhou R, Gao X.
europepmc +1 more source
Antifungal Resistance and the Role of New Therapeutic Agents. [PDF]
Curr Infect Dis Rep, 2022 Logan A, Wolfe A, Williamson JC.
europepmc +1 more source
Olorofim demonstrates <i>in vitro</i> activity against <i>Coccidioides</i> species, including isolates against which fluconazole has reduced activity. [PDF]
Antimicrob Agents ChemotherWiederhold NP +5 more
europepmc +1 more source
An update on the global treatment of invasive fungal infections. [PDF]
Future Microbiol, 2023 Munzen ME +2 more
europepmc +1 more source
Dynamic In Vitro PK/PD Infection Models for the Development and Optimisation of Antimicrobial Regimens: A Narrative Review. [PDF]
Antibiotics (Basel)Wale YM, Roberts JA, Sime FB.
europepmc +1 more source